QianYShiTHaoF, et al. One-year outcomes of dual versus single antithrombotic therapy following iliac vein stenting for acute iliofemoral DVT. Angiology. Published online March 26, 2026. doi:10.1177/00033197261430778
2.
EndoMJahangiriYHorikawaM, et al. Antiplatelet therapy is associated with stent patency after iliocaval venous stenting. Cardiovasc Intervent Radiol. 2018;41(11):1691-1698.
3.
QiuPZhaBXuA, et al. Systematic review and meta-analysis of iliofemoral stenting for post-thrombotic syndrome. Eur J Vasc Endovasc Surg. 2019;57(3):407-416.
4.
AvgerinosEDBlackSvan RijnMJJalaieH.The role and principles of stenting in acute iliofemoral venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2024;12(5):101868.
5.
JahangiriYEndoMAl-HakimRKaufmanJAFarsadK.Early venous stent failure predicted by platelet count and neutrophil/lymphocyte ratio. Circ J. 2019;83(2):320-326.
6.
ZhangJWangNXinTZhuXLangSGeX.Liquiritin mitigates lower extremity deep vein thrombosis by inhibiting inflammation and oxidative stress via the NF-κB signaling pathway. Thromb J. 2025;23(1):51.
